Cytespace Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.43 M
as on 16-11-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -79.53%
(FY 2023)
- Profit -192.90%
(FY 2023)
- Ebitda -129.34%
(FY 2023)
- Net Worth -60.62%
(FY 2023)
- Total Assets -60.29%
(FY 2023)
About Cytespace Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.43 M, as per Ministry of Corporate Affairs (MCA) records.
Ferzaan Engineer, Himanshu Shah, Suresh Ramu, and Three other members serve as directors at the Company.
- CIN/LLPIN
U73100GJ2011PTC064350
- Company No.
064350
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2011
- Date of AGM
19 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cytespace Research?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Ramu  | Director | 11-Mar-2011 | Current |
Gillian Corken  | Director | 01-Sep-2014 | Current |
Gerardus Hoogland  | Director | 01-Nov-2013 | Current |
| Ferzaan Engineer | Director | 01-Apr-2014 | Current |
| Himanshu Shah | Director | 11-Mar-2011 | Current |
| Oppel Greeff | Director | 03-Aug-2015 | Current |
Financial Performance and Corporate Structure Insights of Cytespace Research.
Cytespace Research Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 79.53% decrease. The company also saw a substantial fall in profitability, with a 192.9% decrease in profit. The company's net worth observed a substantial decline by a decrease of 60.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cytespace Research?
In 2023, Cytespace Research had a promoter holding of 2.23% and a public holding of 97.77%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sun Pharma Advanced Research Company LimitedActive 18 years 9 monthsFerzaan Engineer is a mutual person
Cytecare Hospitals Private LimitedActive 10 years 9 monthsFerzaan Engineer, Himanshu Shah and 4 more are mutual person
Eyestem Research Private LimitedActive 9 years 3 monthsSuresh Ramu and Gerardus Hoogland are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cytespace Research?
Cytespace Research has a workforce of 1 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cytespace Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytespace Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
